Stem cell treatment for acute respiratory distress syndrome
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests whether umbilical cord stem cells are safe for people with mild to moderate ARDS. It aims to see if these cells can help reduce lung inflammation and improve breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have been diagnosed with mild to moderate ARDS within the last 5 days
- You have abnormal chest imaging (X-ray or CT) showing fluid in both lungs
- You agree to avoid pregnancy from screening until 3 months after the study ends
- You do not have severe allergies to the study ingredients, including gentamicin
- You have not had certain heart problems, blood clots, or other serious health conditions in the past few months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether human umbilical cord mesenchymal stem cells given through an IV can help people with severe ARDS. It aims to see if the treatment is safe and if it can improve breathing and recovery.
This trial tests an investigational stem cell therapy (JadiCell) for patients with ARDS, a severe lung condition. The treatment aims to reduce lung inflammation and help you recover.
This trial tests whether an injection of stem cells from umbilical cords can help people with severe ARDS (a type of lung failure) recover faster. It is for those who have not improved after standard treatment and whose ARDS is caused by an infection (not COVID-19).
This trial tests if adding stem cells or their growth liquid to standard sepsis treatment helps adults with severe breathing problems. It may improve recovery for those whose family agrees to the study.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This trial tests a new drug called LEAF-4L6715 to see if it helps people with severe acute respiratory distress syndrome (ARDS), a serious lung condition. If you are on a breathing machine and meet the criteria below, you may be able to join.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.